Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pulmonary Vein Isolation Versus SHAM-pulmonary Vein Isolation for Symptomatic Relief in Patients With Atrial Fibrillation- a Randomised Trial - PVI-SHAM-AF

NCT05119231 is registered in ClinicalTrials.gov with University of Leipzig as lead sponsor.

NCT NCT05119231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05119231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pulmonary Vein Isolation Versus SHAM-pulmonary Vein Isolation for Symptomatic Relief in Patients With Atrial Fibrillation- a Randomised Trial - PVI-SHAM-AF
Lead sponsor
University of Leipzig
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 12, 2021
Completion date
November 30, 2026
Enrollment
262 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation